How excluding some benefits from value assessment of new drugs impacts innovation

Publisher: John Wiley & Sons Inc

E-ISSN: 1099-1050|26|12|1813-1825

ISSN: 1057-9230

Source: HEALTH ECONOMICS, Vol.26, Iss.12, 2017-12, pp. : 1813-1825

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract